Show results for
Refine by
Locations
- USA
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia (Us)
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Covid 19 Novel Vaccination Equipment Supplied In Usa
17 equipment items found
Manufactured by:Ocugen, Inc. based inMalvern, PENNSYLVANIA (USA)
Ocugen and Bharat Biotech to Co-Develop COVAXIN™, a Whole-Virion Inactivated COVID-19 Vaccine, for the US ...
Manufactured by:Moderna, Inc. based inCambridge, MASSACHUSETTS (USA)
To learn about mRNA and how spikevax works, watch our Mechanism of Action video that explains the process in a simple and engaging ...
Manufactured by:Akuratemp based inArden, NORTH CAROLINA (USA)
The CDC Vaccine storage and handling tool kit (2019), states that frozen vaccines must be transported, in a portable vaccine freezer unit or qualified container and pack out that maintains temperatures between -50°C and -15°C (-58°F and +5°F) ...
Manufactured by:Masimo Corp based inIrvine, CALIFORNIA (USA)
Masimo SafetyNet-OPEN is a complete, easy-to-implement solution to help you safely bring people back into the workplace and keep them ...
Manufactured by:Pfizer Inc. based in, NEW YORK (USA)
The Pfizer-BioNTech COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older. The emergency use of this product is only authorized for the duration of the declaration ...
Manufactured by:Tonix Pharmaceuticals Holding Corp. based inChatham, NEW JERSEY (USA)
TNX-102 SL is a small, rapidly-disintegrating, under the tongue (sublingual) product candidate containing 2.8 mg of cyclobenzaprine HCl. The unique patented formulation has been designed to optimize the delivery and absorption of cyclobenzaprine for the therapeutic benefit of improving sleep quality, while minimizing the potential residual effects of oral formulations of cyclobenzaprine. TNX-102 ...
Manufactured by:IGeneX based inMilpitas, CALIFORNIA (USA)
IGeneX is now offering the COV5T SARS-CoV-2 Vaccine Response Test Panel, which tests for antibody response and T-cell response. This comprehensive test panel gives patients the ability to monitor their overall response to the ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
IVX-411 targets SARS-CoV-2, the coronavirus that causes COVID-19. Developed using cutting-edge structure-based design techniques at the Institute for Protein Design at the UW School of Medicine, IVX-411, our lead vaccine candidate for COVID-19, is a self-assembling protein nanoparticle that displays 60 copies of the SARS-CoV-2 spike (S) glycoprotein receptor-binding domain (RBD) in a highly ...
Manufactured by:Meissa Vaccines, Inc. based inRedwood City, CALIFORNIA (USA)
The attenuation of a virus to produce a vaccine must balance reducing its virulence while retaining its ability to stimulate an effective immune response, or immunogenicity. Natural RSV infection does not stimulate a robust immune response, and immunity following SARS-CoV-2 infection wanes, so vaccine technologies that enhance immunogenicity are required. AttenuBlock is Meissa's proprietary ...
Manufactured by:Meissa Vaccines, Inc. based inRedwood City, CALIFORNIA (USA)
Meissa is developing a live attenuated COVID-19 vaccine candidate, MV-014-212, to induce mucosal and systemic immunity and protect against SARS-CoV-2, the novel coronavirus that causes COVID-19. Like Meissa’s RSV vaccine candidate, MV-014-212 offers significant potential ...
Manufactured by:Environmental Specialties, LLC an EMCOR Group, Inc. based inRaleigh, NORTH CAROLINA (USA)
Our popular Ultra-Low Temp Suite utilizes an innovative chamber-within-a-chamber design to support the stringent bio-repository and pharmaceutical requirements of ultra-cold temperature walk-in freezer vaults. It offers a more energy ef?cient alternative to the traditional “freezer farm” approach, while still delivering maximum capacity, multi-temperature storage ?exibility, and ...
Manufactured by:Meissa Vaccines, Inc. based inRedwood City, CALIFORNIA (USA)
Respiratory viruses are one of the biggest threats to human health. Vaccines are the most effective healthcare tool to combat infectious diseases and have saved more lives than any other type of medicine. Meissa is dedicated to creating safe, potent, stable, and accessible intranasal live attenuated vaccines that can prevent infection and disease. Meissa’s RSV and COVID-19 live attenuated ...
by:Kephera Diagnostics, LLC based inFramingham, MASSACHUSETTS (USA)
The COVI-QUANT™ test will give you an answer. It represents the latest generation of testing technology that will provide a numerical value for your antibody level, not just yes or no. COVI-QUANT™ is an ELISA test available through Kephera’s CLIA laboratory. Studies show that not all individuals develop a strong immune response after COVID-19 infection or vaccination, especially ...
Manufactured by:Tonix Pharmaceuticals Holding Corp. based inChatham, NEW JERSEY (USA)
TNX-1850 is the planned new version of the TNX-1800 vaccine that encodes spike protein from SARS-CoV-2 BA.2 ...
Manufactured by:Immudex ApS based inVirum, DENMARK
Reliable Identification of SARS-CoV-2-Specific T-Cell Responses. T Cells Take the Lead in COVID-19. A deeper understanding of viral-specific T-cell responses to COVID-19 is needed to explore vaccine responses, long-term immunity, predict patients at risk, and even prepare for the next pandemic. T-cell responses are believed to be important for protection against severe disease through the ...
Manufactured by:AIVITA Biomedical, Inc. based in, CALIFORNIA (USA)
AIVITA Biomedical is using its patient-specific vaccine platform to develop a rapidly scalable vaccine candidate, AV-COVID-19, for the novel coronavirus (SARS-CoV-2). AIVITA’s personalized vaccine begins with a basic blood draw, from which the recipient’s own immune cells are ...
Manufactured by:Mokon based inBuffalo, NEW YORK (USA)
Mokon's Pura-Therm heating and chilling system provides integrated temperature control solutions crucial for the medical and pharmaceutical industries, notably during the development of COVID-19 vaccines. This comprehensive system combines heating and chilling functions within a single, compact unit, which facilitates control over a temperature range of 20°F to 250°F (-7°C to ...